Move Strengthens America’s Supply Chain and Supports COVID-19 Response.
Updates From Phlow™
New Pharma Company Lands $354 Million Government Contract to Produce Coronavirus Drugs in the U.S.
The U.S. government signed a $354 million four-year contract with new pharmaceutical company Phlow Corp. to increase American production of medications that may help treat Covid-19 in a bid to avoid potential supply chain shortages, with the potential to extend the contract to $812 million for the next ten years.